House Meets to Discuss PDUFA, MDUFA User Fees

The House Energy and Commerce Committee is meeting 18 April starting at 10:15 AM to discuss various proposed user fee agreements, including the Prescription Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA) reauthorization bills on 18 April.

The hearing, entitled "US Food and Drug Administration User Fees 2012: How Innovation Helps Patients and Jobs," will be taking place at room 2123 of the Rayburn House Office Building.

A webcast of the meeting will be available at http://republicans.energycommerce.house.gov/ on the day of the meeting or at the Committee's UStream account. The hearings are typically archived on the Committee's YouTube account.

Prior committee hearings include:

• 8 March - FDA User Fees 2012: Hearing on Issues Related to Accelerated Approval, Medical Gas, Antibiotic Development and Downstream Pharmaceutical Supply Chain
• 1 March - Prescription Drug Diversion: Combating the Scourge
• 17 February - Impact of Medical Device Regulation on Jobs and Patients
• 15 February - Reauthorization of MDUFA: What It Means for Jobs, Innovation and Patients
• 9 February - Review of the Proposed Generic Drug and Biosimilars User Fees and Further Examination of Drug Shortages
• 1 February - Reauthorization of PDUFA: What It Means for Jobs, Innovation, and Patients

Read more:

E&C - FDA User Fees 2012: How Innovation Helps Patients and Jobs

Live: Webcast of the Committee Meeting (Link Only Good for 18 April)